Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Biological factors of the tumour response to electrochemotherapy : review of the evidence and a research roadmap
Authors:ID Serša, Gregor (Author)
ID Uršič Valentinuzzi, Katja (Author)
ID Čemažar, Maja (Author)
ID Heller, Richard (Author)
ID Omerzel, Maša (Author)
ID Campana, Luca Giovanni (Author)
Files:.pdf PDF - Presentation file, download (1,32 MB)
MD5: E13D0298BFF613C5C23E5BB3F1B7FF79
 
Language:English
Typology:1.02 - Review Article
Organization:Logo OI - Institute of Oncology
Abstract:The beneficial effects of electrochemotherapy (ECT) for superficial tumours and, more recently, deepseated malignancies in terms of local control and quality of life are widely accepted. However, the variability in responses across histotypes needs to be explored. Currently, patient selection for ECT is based on clinical factors (tumour size, histotype, and exposure to previous oncological treatments), whereas there are no biomarkers to predict the response to treatment. In this field, two major areas of investigation can be identified, i.e., tumour cell characteristics and the tumour microenvironment (vasculature, extracellular matrix, and immune infiltrate). For each of these areas, we describe the current knowledge and discuss how to foster further investigation. This review aims to provide a summary of the currently used guiding clinical factors and delineates a research roadmap for future studies to identify putative biomarkers of response to ECT. These biomarkers may allow researchers to improve ECT practice by customising treatment parameters, manipulating the tumour and its microenvironment, and exploring novel therapeutic combinations.
Keywords:biological factors, biomarkers, electrochemotherapy, bleomycin, cisplatin
Publication status:Published
Publication version:Version of Record
Publication date:11.03.2021
Publisher:Elsevier
Year of publishing:2021
Number of pages:str. 1836-1846
Numbering:Vol. 47, iss. 8
PID:20.500.12556/DiRROS-15582 New window
UDC:602
ISSN on article:0748-7983
DOI:10.1016/j.ejso.2021.03.229 New window
COBISS.SI-ID:57155587 New window
Copyright:by Authors
Publication date in DiRROS:23.09.2022
Views:936
Downloads:302
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:European journal of surgical oncology
Shortened title:Eur. j. surg. oncol.
Publisher:Academic Press
ISSN:0748-7983
COBISS.SI-ID:6045447 New window

Document is financed by a project

Funder:ARRS - Slovenian Research Agency
Project number:J3-9269-2018
Name:Klinično farmakološki pristop k optimizaciji terapevtske koncentracije bleomicina zazdravljenje z elektrokemoterapijo

Funder:ARRS - Slovenian Research Agency
Project number:P3-0003-2015
Name:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Funder:ARRS - Slovenian Research Agency
Project number:Z3-2651-2020
Name:Elektrokemoterapija kot in situ vakcinacija

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:22.09.2022

Secondary language

Language:Slovenian
Keywords:biološki dejavniki, biološki označevalci, elektrokemoterapija, bleomycin, cisplatin


Back